Cannabinoid Biosynthesis Market Size & Share, by Type (CBD, CBG, THC); Application (Anxiety, Pain Management, Nausea Treatment, Appetite Stimulation) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4142
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Companies Dominating the Cannabinoid Biosynthesis Landscape

top-features-companies
    • Amyris, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Willow Bioscience Inc.
    • Cronos Group
    • Zymergen Inc.
    • Constellation Brands, Inc.
    • Jazz Pharmaceuticals plc
    • Canopy Growth Corporation
    • InMed Pharmaceuticals Inc.
    • Hyasynth Biologicals Inc.
    • Renew Biopharma, Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Trulieve Cannabis Corp. completed the acquisition of Harvest Health & Recreation, this merger is to create the largest chain of marijuana company in the United States by opening 149 dispensaries and operation in 11 states.

  • Jazz Pharmaceuticals announced the acquisition of GW Pharmaceuticals plc, a leading player of science and development of cannabis-based medicine. With the purchase of GW, the commercial portfolio of Jazz Pharmaceuticals is to introduced diversity in medicine


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4142
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing sales of cannabis-based products, rise in the partnership among the companies, higher legalization of cannabis use for adults, and rising use of cannabis for medical purposes are the major factors driving the market growth.

The market is anticipated to attain a CAGR of ~16% over the forecast period, i.e., 2023 – 2035.

Strict rules and regulations for the production of cannabis, and misuse of cannabis are estimated to be the growth hindering factors for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Amyris, Inc., Willow Bioscience Inc., Cronos Group, Zymergen Inc., Constellation Brands, Inc., Jazz Pharmaceuticals plc, Canopy Growth Corporation, InMed Pharmaceuticals Inc., Hyasynth Biologicals Inc., and Renew Biopharma, Inc.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, application, and by region.

The CBD segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying